The genomic landscape of 2,023 colorectal cancers
2024 · Nature · 130 citations
https://doi.org/10.1038/s41586-024-07747-9
G
Giulio Caravagna
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
239
Papers
2.8K
Citations
24
h-index
50
i10-index
Giulio Caravagna is an academic researcher from University of Trieste. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Epigenetics and DNA Methylation & Cancer Immunotherapy and Biomarkers. The author has an h-index of 24, co-authored 204 publications.
ORCID: 0000-0003-4240-3265Papers by this author
worksExploiting evolutionary steering to induce collateral drug sensitivity in cancer
2020 · Nature Communications · 126 citations
https://doi.org/10.1038/s41467-020-15596-z
The co-evolution of the genome and epigenome in colorectal cancer
2022 · Nature · 119 citations
https://doi.org/10.1038/s41586-022-05202-1
Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors
2023 · Nature Genetics · 73 citations
https://doi.org/10.1038/s41588-023-01313-1
Long-term lineage commitment in haematopoietic stem cell gene therapy
2024 · Nature · 37 citations
https://doi.org/10.1038/s41586-024-08250-x
Cancer genomes tolerate deleterious coding mutations through somatic copy number amplifications of wild-type regions
2023 · Nature Communications · 19 citations
https://doi.org/10.1038/s41467-023-39313-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat